Frequency of Multiple Molecular Diagnoses About 5 Percent

This article originally appeared here.
Share this content:
Frequency of Multiple Molecular Diagnoses About 5 Percent
Frequency of Multiple Molecular Diagnoses About 5 Percent

THURSDAY, Dec. 8, 2016 (HealthDay News) -- About 5 percent of patients for whom whole-exome sequencing is informative have multiple molecular diagnoses, according to research published online Dec. 7 in the New England Journal of Medicine.

Jennifer E. Posey, M.D., Ph.D., from the Baylor College of Medicine in Houston, and colleagues conducted a retrospective analysis of data from 7,374 unrelated patients who had been referred for whole-exome sequencing. The authors examined the frequency and clinical characteristics for patients with more than one molecular diagnosis, and calculated the phenotypic similarity between molecularly diagnosed pairs of diseases.

The researchers found that 28.2 percent of patients had a molecular diagnosis; of these, 4.9 percent had diagnoses involving two or more disease loci. When available, parental samples were analyzed; de novo variants accounted for 67.8 and 51.7 percent of pathogenic variants in autosomal dominant and X-linked disease genes, respectively. Among patients with two monoallelic variants, 44.7 percent had both variants de novo. Twelve patients with multiple diagnoses (11.9 percent) had causal copy-number variants. For patients in whom the phenotype resulted from two distinct mendelian disorders affecting different organ systems (50 patients), the phenotypic similarity score was significantly lower compared with patients with disorders that had overlapping features (30 patients; median score, 0.21 versus 0.36).

"Our data challenge the notion that a diagnostic investigation is necessarily complete after a single genetic diagnosis has been obtained," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Progress Made on Genetic Test for Anal Cancer

Progress Made on Genetic Test for Anal Cancer

But research is still in early stages

Four Separate Events Led to Zika's Introduction Into Florida

Four Separate Events Led to Zika's Introduction Into ...

Virus strains came from the Caribbean and Latin America, researchers say

New Health Care Act Could Result in 23 Million Losing Insurance

New Health Care Act Could Result in 23 ...

While premiums may lower over the long-term, many would face much higher out-of-pocket costs

is free, fast, and customized just for you!

Already a member?

Sign In Now »